396 related articles for article (PubMed ID: 26560078)
1. Serum irisin levels are lower in patients with breast cancer: association with disease diagnosis and tumor characteristics.
Provatopoulou X; Georgiou GP; Kalogera E; Kalles V; Matiatou MA; Papapanagiotou I; Sagkriotis A; Zografos GC; Gounaris A
BMC Cancer; 2015 Nov; 15():898. PubMed ID: 26560078
[TBL] [Abstract][Full Text] [Related]
2. Association of serum concentrations of irisin and the adipokines adiponectin and leptin with epicardial fat in cardiovascular surgery patients.
Kaneda H; Nakajima T; Haruyama A; Shibasaki I; Hasegawa T; Sawaguchi T; Kuwata T; Obi S; Arikawa T; Sakuma M; Amano H; Toyoda S; Fukuda H; Inoue T
PLoS One; 2018; 13(8):e0201499. PubMed ID: 30071056
[TBL] [Abstract][Full Text] [Related]
3. Adipocytokines and breast cancer risk.
Hou WK; Xu YX; Yu T; Zhang L; Zhang WW; Fu CL; Sun Y; Wu Q; Chen L
Chin Med J (Engl); 2007 Sep; 120(18):1592-6. PubMed ID: 17908478
[TBL] [Abstract][Full Text] [Related]
4. Serum resistin is inversely related to breast cancer risk in premenopausal women.
Georgiou GP; Provatopoulou X; Kalogera E; Siasos G; Menenakos E; Zografos GC; Gounaris A
Breast; 2016 Oct; 29():163-9. PubMed ID: 27521488
[TBL] [Abstract][Full Text] [Related]
5. Serum irisin levels in new-onset type 2 diabetes.
Choi YK; Kim MK; Bae KH; Seo HA; Jeong JY; Lee WK; Kim JG; Lee IK; Park KG
Diabetes Res Clin Pract; 2013 Apr; 100(1):96-101. PubMed ID: 23369227
[TBL] [Abstract][Full Text] [Related]
6. Resistin, visfatin, adiponectin, and leptin: risk of breast cancer in pre- and postmenopausal saudi females and their possible diagnostic and predictive implications as novel biomarkers.
Assiri AM; Kamel HF; Hassanien MF
Dis Markers; 2015; 2015():253519. PubMed ID: 25838618
[TBL] [Abstract][Full Text] [Related]
7. Leptin, adiponectin, tumor necrosis factor α, and irisin concentrations as factors linking obesity with the risk of atrial fibrillation among inpatients with cardiovascular diseases.
Anaszewicz M; Wawrzeńczyk A; Czerniak B; Banaś W; Socha E; Lis K; Żbikowska-Gotz M; Bartuzi Z; Budzyński J
Kardiol Pol; 2019 Nov; 77(11):1055-1061. PubMed ID: 31553329
[TBL] [Abstract][Full Text] [Related]
8. Association between circulating irisin levels and the promotion of insulin resistance during the weight maintenance period after a dietary weight-lowering program in obese patients.
Crujeiras AB; Zulet MA; Lopez-Legarrea P; de la Iglesia R; Pardo M; Carreira MC; Martínez JA; Casanueva FF
Metabolism; 2014 Apr; 63(4):520-31. PubMed ID: 24439241
[TBL] [Abstract][Full Text] [Related]
9. Adipocyte fatty acid-binding protein as a novel prognostic factor in obese breast cancer patients.
Hancke K; Grubeck D; Hauser N; Kreienberg R; Weiss JM
Breast Cancer Res Treat; 2010 Jan; 119(2):367-7. PubMed ID: 19842034
[TBL] [Abstract][Full Text] [Related]
10. Elevated serum visfatin/nicotinamide phosphoribosyl-transferase levels are associated with risk of postmenopausal breast cancer independently from adiponectin, leptin, and anthropometric and metabolic parameters.
Dalamaga M; Karmaniolas K; Papadavid E; Pelekanos N; Sotiropoulos G; Lekka A
Menopause; 2011 Nov; 18(11):1198-204. PubMed ID: 21712732
[TBL] [Abstract][Full Text] [Related]
11. Circulating irisin levels reflect visceral adiposity in non-diabetic patients undergoing hemodialysis.
Yilmaz H; Cakmak M; Darcin T; Inan O; Sahiner E; Demir C; Aktas A; Bilgic MA; Akcay A
Ren Fail; 2016 Jul; 38(6):914-9. PubMed ID: 27089215
[TBL] [Abstract][Full Text] [Related]
12. Assessment of Irisin, Adiponectin and Leptin Levels in Patients with Schizophrenia.
Erzin G; Topcuoglu C; Kotan VO; Bayram S; Fountoulakis K
Endocr Metab Immune Disord Drug Targets; 2018 Feb; 18(2):163-169. PubMed ID: 29219062
[TBL] [Abstract][Full Text] [Related]
13. Irisin, a novel myokine is an independent predictor for sarcopenia and carotid atherosclerosis in dialysis patients.
Lee MJ; Lee SA; Nam BY; Park S; Lee SH; Ryu HJ; Kwon YE; Kim YL; Park KS; Oh HJ; Park JT; Han SH; Ryu DR; Kang SW; Yoo TH
Atherosclerosis; 2015 Oct; 242(2):476-82. PubMed ID: 26298738
[TBL] [Abstract][Full Text] [Related]
14. Hyperirisinemia is independently associated with subclinical hypothyroidism: correlations with cardiometabolic biomarkers and risk factors.
Stratigou T; Dalamaga M; Antonakos G; Marinou I; Vogiatzakis E; Christodoulatos GS; Karampela I; Papavassiliou AG
Endocrine; 2018 Jul; 61(1):83-93. PubMed ID: 29455364
[TBL] [Abstract][Full Text] [Related]
15. Serum adiponectin and leptin levels in Taiwanese breast cancer patients.
Chen DC; Chung YF; Yeh YT; Chaung HC; Kuo FC; Fu OY; Chen HY; Hou MF; Yuan SS
Cancer Lett; 2006 Jun; 237(1):109-14. PubMed ID: 16019138
[TBL] [Abstract][Full Text] [Related]
16. Serum irisin associates with breast cancer to spinal metastasis.
Zhang ZP; Zhang XF; Li H; Liu TJ; Zhao QP; Huang LH; Cao ZJ; He LM; Hao DJ
Medicine (Baltimore); 2018 Apr; 97(17):e0524. PubMed ID: 29703023
[TBL] [Abstract][Full Text] [Related]
17. Serum levels of the myokine irisin in relation to metabolic and renal function.
Ebert T; Focke D; Petroff D; Wurst U; Richter J; Bachmann A; Lössner U; Kralisch S; Kratzsch J; Beige J; Bast I; Anders M; Blüher M; Stumvoll M; Fasshauer M
Eur J Endocrinol; 2014 Apr; 170(4):501-6. PubMed ID: 24399249
[TBL] [Abstract][Full Text] [Related]
18. Serum irisin levels correlated to peritoneal dialysis adequacy in nondiabetic peritoneal dialysis patients.
Tan Z; Ye Z; Zhang J; Chen Y; Cheng C; Wang C; Liu X; Lou T; Peng H
PLoS One; 2017; 12(4):e0176137. PubMed ID: 28445520
[TBL] [Abstract][Full Text] [Related]
19. Serum irisin levels in patients with psoriasis.
Baran A; Myśliwiec H; Kiluk P; Świderska M; Flisiak I
J Dermatolog Treat; 2017 Jun; 28(4):304-308. PubMed ID: 27786588
[TBL] [Abstract][Full Text] [Related]
20. Circulating irisin in healthy, young individuals: day-night rhythm, effects of food intake and exercise, and associations with gender, physical activity, diet, and body composition.
Anastasilakis AD; Polyzos SA; Saridakis ZG; Kynigopoulos G; Skouvaklidou EC; Molyvas D; Vasiloglou MF; Apostolou A; Karagiozoglou-Lampoudi T; Siopi A; Mougios V; Chatzistavridis P; Panagiotou G; Filippaios A; Delaroudis S; Mantzoros CS
J Clin Endocrinol Metab; 2014 Sep; 99(9):3247-55. PubMed ID: 24915120
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
